Ticker
MRSNCompany Name
MERSANA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -70.28M | -202.14% | $ 34.77M |
3/31/2025 | $ -69.94M | -205.68% | $ 34.01M |
12/31/2024 | $ -64.9M | -160.26% | $ 40.5M |
9/30/2024 | $ -70.18M | -201.46% | $ 34.84M |
6/30/2024 | $ -100.72M | -336.45% | $ 29.94M |
3/31/2024 | $ -130.72M | -341.33% | $ 38.3M |
12/31/2023 | $ -167.6M | -454.75% | $ 36.85M |
9/30/2023 | $ -193.06M | -472.7% | $ 40.84M |
6/30/2023 | $ -211.35M | -545.89% | $ 38.72M |
3/31/2023 | $ -209.53M | -647.76% | $ 32.35M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for MERSANA THERAPEUTICS INC is calculated as follows: EBIT [ $ -75.09M ] / Revenues [ $ 860K ]
(=) EBIT % [ -8731.63% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |